Carcinogenesis, Vol. 21, No. 12, 2267-2274,
December 2000
© 2000 Oxford University Press
CARCINOGENESIS |
Regulation of prostaglandin endoperoxide H synthase-2 induction by dioxin in rat hepatocytes: possible c-Src-mediated pathway
Department of Experimental Toxicology, Medical Institute of Environmental Hygiene at the Heinrich-Heine-University, 40225 Duesseldorf,
1 Institute of Toxicology, Heinrich-Heine-University, 40225 Duesseldorf and
2 Institute of Occupational Physiology at the University of Dortmund, 44139 Dortmund, Germany
The tumor promoter 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is known to increase the expression of prostaglandin endoperoxide H synthase (PGHS)-2. This study focused on the regulatory mechanism of TCDD-mediated transcriptional activation of PGHS-2. Treatment of rat hepatocytes with TCDD led to a dose-dependent induction of PGHS-2 mRNA levels associated with an increased synthesis of prostaglandin E2, whereas expression of PGHS-1 was not affected. In vitro experiments with c-Src inhibitors, such as herbimycin A and geldanamycin, and in vivo studies with c-Src-deficient mice indicated that up-regulation of PGHS-2 but not the cytochrome P450 gene CYP1A1 by TCDD is mediated via a c-Src-dependent pathway. Transient transfection studies with different reporter constructs of the murine PGHS-2 promoter mutated in the xenobiotic-responsive element (XRE) or CCAAT/enhancer binding protein (C/EBP) element revealed that a C/EBP-binding site is an important regulatory cis-acting factor for trans-activation of the PGHS-2 gene by TCDD. Consistent with transfection studies, gel mobility shift assays showed that TCDD led to an enhanced DNA-binding activity of C/EBPß transcription factor. The experimental data presented in this article reveal a XRE-independent and c-Src-mediated activation of the PGHS-2 gene by TCDD through the C/EBP response element located in its promoter region.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. F.A. Vogel, W. Li, E. Sciullo, J. Newman, B. Hammock, J. R. Reader, J. Tuscano, and F. Matsumura Pathogenesis of Aryl Hydrocarbon Receptor-Mediated Development of Lymphoma Is Associated with Increased Cyclooxygenase-2 Expression Am. J. Pathol., November 1, 2007; 171(5): 1538 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Lovgren, M. Kovarova, and B. H. Koller cPGES/p23 Is Required for Glucocorticoid Receptor Function and Embryonic Growth but Not Prostaglandin E2 Synthesis Mol. Cell. Biol., June 15, 2007; 27(12): 4416 - 4430. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fritsche, C. Schafer, C. Calles, T. Bernsmann, T. Bernshausen, M. Wurm, U. Hubenthal, J. E. Cline, H. Hajimiragha, P. Schroeder, et al. Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation PNAS, May 22, 2007; 104(21): 8851 - 8856. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. A. Vogel, E. Sciullo, S. Park, C. Liedtke, C. Trautwein, and F. Matsumura Dioxin Increases C/EBP{beta} Transcription by Activating cAMP/Protein Kinase A J. Biol. Chem., March 5, 2004; 279(10): 8886 - 8894. [Abstract] [Full Text] [PDF] |
||||



